Evidence map›Paper›PMID 39994815›Full record

ReviewCritical care (London, England)2025

A narrative review on the future of ARDS: evolving definitions, pathophysiology, and tailored management.

Lou'i Al-Husinat, Saif Azzam, Sarah Al Sharie, Mohammad Araydah, Denise Battaglini, Suhib Abushehab, Gustavo A Cortes-Puentes, Marcus J Schultz, Patricia R M Rocco

Registry-linked trialAbstract readReview
In one paragraph

Review in Critical care (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07793565 (A Randomized Controlled Trial of Early EIT-Guided PEEP Titration on Pulmonary Physiology in Moderate-to-Severe ARDS Patients Undergoing Prone Positioning), which is not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07793565 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Randomized Controlled Trial of Early EIT-Guided PEEP Titration on Pulmonary Physiology in Moderate-to-Severe ARDS Patients Undergoing Prone Positioning

TypeinterventionalSponsorXIE MINRan2026 to 2027Enrolled40ConditionsAcute Respiratory Distress Syndrome (ARDS)ArmsEIT-Guided PEEP Titration Group, ARDSNet/PEEP-FiO₂ Table
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. SERPINE1 in ARDS: an emerging regulator of inflammation-coagulation-fibrinolysis crosstalk.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  5. Association between steroid therapy and increased mortality in patients at risk for ARDS.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2026
    Article
  6. Article
  7. Cytokine storm in acute respiratory distress syndrome.Journal of intensive medicine · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. ACT001 alleviates sepsis-induced acute lung injury by downregulating PANoptosis via the JAK2/STAT3 pathway.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lou'i Al-HusinatDepartment of Clinical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan.
Saif AzzamFaculty of Medicine, Yarmouk University, Irbid, Jordan.
Sarah Al SharieOffice of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan.
Mohammad AraydahDepartment of Internal Medicine, Istishari Hospital, Amman, Jordan.
Denise BattagliniDepartment of Surgical Sciences and Integrated Diagnostics (DISC), University of Genova, Genoa, Italy.
Suhib AbushehabDepartment of Medicine, University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), Bristol, UK.
Gustavo A Cortes-PuentesDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Marcus J SchultzDepartment of Intensive Care, Amsterdam UMC, Locatie AMC, Amsterdam, The Netherlands.
Patricia R M RoccoLaboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. prmrocco@gmail.com.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 0306599/2023-6Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/210.777/2021
6 · The paper itself

Abstract

Acute respiratory distress syndrome (ARDS) is a severe complication of critical illness, characterized by bilateral lung infiltrates and hypoxemia. Its clinical and pathophysiological heterogeneity poses challenges for both diagnosis and treatment. This review outlines the evolution of ARDS definitions, discusses the underlying pathophysiology of ARDS, and examines the clinical implications of its heterogeneity. Traditional ARDS definitions required invasive mechanical ventilation and relied on arterial blood gas measurements to calculate the PaO

Indexed as

Respiratory Distress SyndromeHumansRespiration, ArtificialAcute respiratory distress syndromeHeterogeneityOmicsPathophysiologyPersonalized medicineSubphenotype

Identifiers

PMID39994815
PMCPMC11852867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.